ESC Premium Access

One-year outcomes of patients with hypertrophic cardiomyopathy according to levels of inflammatory biomarkers

Congress Presentation

About the speaker

Doctor Michele Golino

VCU Health Pauley Heart Center, Richmond (United States of America)
1 presentation
0 follower

6 more presentations in this session

CMR phenotypes and clinical outcomes in NYHA class I versus II-IV hypertrophic cardiomyopathy: identifying high-risk asymptomatic patients

Speaker: Doctor D. Labib (Calgary, CA)

Thumbnail

High-intensity exercise-related sudden cardiac death in hypertrophy cardiomyopathy

Speaker: Doctor H. Lee (Seoul, KR)

Thumbnail

The relationship between serum lumican levels and myocardial fibrosis in patients with hypertrophic cardiomyopathy

Speaker: Doctor E. Hancioglu (Hatay, TR)

Thumbnail

Invasive quantitative assessment of coronary microvascular dysfunction in patients with hypertrophic cardiomyopathy

Speaker: Doctor M. Marques Antunes (Lisboa, PT)

Thumbnail

Prolonged ventricular activation time as a novel biomarker identifying burn-out phase of hypertrophic cardiomyopathy

Speaker: Doctor K. Fragkiadakis (Heraklion, GR)

Thumbnail

Access the full session

Hypertrophic cardiomyopathy: risk prediction and outcomes

Speakers: Doctor M. Golino, Doctor D. Labib, Doctor H. Lee, Doctor E. Hancioglu, Doctor M. Marques Antunes...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations